학술논문

An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Document Type
Article
Source
In: OncoImmunology. (OncoImmunology, 2021, 10(1))
Subject
Language
English
ISSN
2162402X
21624011